Saturday, July 26, 2014 Last update: 12:33 AM - All Company Technology News Since 1996

Three Top Theorem Executives Slated to Speak at Partnerships in Clinical Trials

Companies mentioned in this article: Theorem Clinical Research

KING OF PRUSSIA, Pa. -- (BUSINESS WIRE) -- Three top executives from Theorem Clinical Research will be on the agenda at the 23rd Annual Partnerships in Clinical Trials in Las Vegas, March 31-April 2.

John Potthoff, Theorem president and CEO joins the Fireside Chat, from 2-3 p.m. Monday, March 31, speaking on “The Real Impact of Going Public/Private on Business.”

Alison Taber, Theorem vice president of global data management, will join a panel discussion on the topic of “Risk-Based Study Management for Small to Midsized Companies,” from 2:30-3:30 p.m. March 31.

Rounding out Theorem’s speaking appearances at PCT will be Mark Penniston, Theorem executive vice president and general manager, Clinical Analytics, discussing visual analytics and real-world applications at 4:30 p.m. Tuesday, April 1.

“The amount of data collected in modern clinical trials can be completely overwhelming unless you have ways to see it that make it meaningful,” Penniston said. “Theorem has been developing advanced visual analytics tools and techniques that allow us to present complex clinical information graphically, giving you a quicker grasp and greater insight into the meaning the numbers actually represent.”

Theorem will be showcasing visual analytics capabilities at Booth 1208 during the show. Visitors to the booth will also have a chance to see the world in a whole new way by taking a short survey and registering to win the unique Google Glass that Theorem will be giving away at the end of the conference.

For more information, visit

About Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's top pharmaceutical, biotech and medical device companies. As a forerunner in medical device and drug-device combination trials with notable capabilities in pharmaceuticals and biologics, Theorem offers deep expertise in a broad range of therapeutic areas and in all phases of development. With some of the industry's top scientists and most advanced clinical analytics capabilities, Theorem ensures smooth-running, successful trials. For the full-service, right-size global research partner, don't think twice. THINK THEOREM.

Copyright © Business Wire 2014

For Theorem Clinical Research:
Lea Studer, 1 308-237-5567